Search

Search Constraints

You searched for: Author/Creator Behrend, Clint E

Search Results

1. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. (May 2023)